Shaers of CVS Health Corporation (NYSE:CVS) have been recommended as a long term growth pick according to Beta Research. With the firm’s stock price currently trading around $70.44, the firm has proven a solid track record of growth over the past few years. Investors might consider the stock as a long term growth candidate as the firm has yielded 13.60% earnings per share growth over the past 5 years and 10.60% revenue growth over that same time frame.
Let’s take a look at how the stock has been performing recently. Over the past twelve months, CVS Health Corporation (NYSE:CVS)’s stock was -10.73%. Over the last week of the month, it was 2.16%, -11.12% over the last quarter, and -7.72% for the past six months.
Over the past 50 days, CVS Health Corporation’s stock is -16.14% off of the high and 6.00% removed from the low. Their 52-Week High and Low are as follows: -16.86% (High), 6.00%, (Low).
Despite the past success, investors want to know where the stock is headed from here. Analysts covering the shares have a consensus short-term price target of $84.68 on the equity. Analysts have a consensus recommendation of 2.20 based on a 1 to 5 scale where 1 represents a Strong Buy and 5 a Strong Sell.